The 2nd International Symposium on ‘Streptococcus agalactiae’ Disease took place on the 3rd – 5th November, London, UK.

The 3rd International Symposium on ‘Streptococcus agalactiae’ Disease will take place in Brazil in 2023.

Group B streptococcus (GBS) is a type of bacteria that can exist in the female reproductive tract without causing symptoms. Up to 30% of healthy women can carry group B strep, and it usually does not cause problems. However, sometimes it can lead to serious infection of the bloodstream, infection of the placenta, or urinary tract infection. Group B strep can also have serious consequences for the baby, causing potentially life-threatening infections in the newborn, including meningitis, pneumonia, and sepsis.

Who is at risk from Group B Streptococcus? Source: Clinical Infectious Diseases Journal (2017) Copyright: LSHTM 2017

The London ISSAD Conference was a free interactive and comprehensive platform covering topics ranging from the GBS disease burden and challenges to the epidemiology, immunology, and vaccinology of GBS and everything in between.

For further information about Group B Strep and Group B Strep Support please visit our partners Group B Strep Support and Group B Strep International.

We look forward to welcoming you to the next event in Brazil, 2023!